您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Milnacipran-d5(hydrochloride)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Milnacipran-d5(hydrochloride)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Milnacipran-d5(hydrochloride)图片
包装:1mg
规格:98%
市场价:5111元
分子量:287.8

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx22956
CAS:N/A
分子式:C15H17D5N2O.HCl
分子量:287.8
溶解度:DMSO: Soluble,Methanol: Soluble
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Milnacipran-d5is intended for use as an internal standard for the quantification of milnacipran by GC- or LC-MS. Milnacipran is an orally bioavailable serotonin and norepinephrine reuptake inhibitor (SNRI).1It selectively inhibits the human serotonin transporter and norepinephrine transporter over the dopamine transporter (IC50s = 420, 77, and 6,100 nM, respectively). It also selectively inhibits sodium-dependent serotonin and norepinephrine uptake over dopamine uptake in rat cerebral cortical synaptosomes (IC50s = 28.0, 29.6, and >10,000 nM, respectively).2Milnacipran is an antagonist of the serotonin (5-HT) receptor subtype 5-HT3Aas well as nicotinic acetylcholine receptors (nAChRs; IC50s = 63.5 and 14.3 μM, respectively) but does not inhibit other 5-HT, adrenergic, dopamine, muscarinic acetylcholine, histamine, NMDA, sigma, opioid, or GABA receptors (Kis = >10,000 nM).2,3In vivo, milnacipran (30 mg/kg) increases withdrawal threshold and latency in response to tactile and heat stimulation, respectively, in nerve-ligated mice.4Formulations containing milnacipran have been used in the treatment of fibromyalgia pain.


1.Chen, C., Dyck, B., Fleck, B.A., et al.Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitorsBioorg. Med. Chem.18(4)1346-1349(2008) 2.Mochizuki, D., Tsujita, R., Yamada, S., et al.Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in ratsPsychopharmacology (Berl)162(3)323-332(2002) 3.Ueta, K., Suzuki, T., Uchida, I., et al.In vitro inhibition of recombinant ligand-gated ion channels by high concentrations of milnacipranPsychopharmacology (Berl)175(2)241-246(2004) 4.Suzuki, T., Ueta, K., Tamagaki, S., et al.Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligationAnesth. Analg.106(4)1309-1315(2008)